Perinatal characteristics and risk of neuroblastoma.

作者: Kimberly J. Johnson , Susan E. Puumala , John T. Soler , Logan G. Spector

DOI: 10.1002/IJC.23645

关键词: Gestational ageMaternal hypertensionRisk factorEtiologyConfidence intervalPediatricsBirth YearPopulationMedicineHazard ratio

摘要: Neuroblastoma (NB), a tumor of the sympathetic nervous system, is most common infant malignancy. The etiology NB largely unknown. We explored association between birth record variables and subsequent development in population-based case-cohort study Minnesota by linking cancer registries. cases included 155 children born during 1976-2004 who were diagnosed from 28 days through 14 years age. comparison group 8,752 individuals randomly sampled cohort cases. Cox proportional hazards regression was used to calculate hazard ratios (HRs) 95% confidence intervals (CIs). Controlling for year sex, maternal history one fetal loss (HR = 1.7, CI 1.2-2.5), prenatal drug-use (recorded starting 1992) 5.7, 2.3-14) child's small size gestational age 2.1, 1.1-4.0) significantly associated with NB. Age specific analyses indicated that hypertension 3.0, 1.3-7.2) <20 2.6, 1.1-6.1) increased risks only. Our provides evidence few perinatal exposures as recorded records may play role etiology.

参考文章(38)
A T Meadows, S Kramer, E Ward, K E Malone, Medical and drug risk factors associated with neuroblastoma: a case-control study. Journal of the National Cancer Institute. ,vol. 78, pp. 797- 804 ,(1987)
Mohammad M. Agha, Jack I. Williams, Loraine Marrett, Teresa To, Alvin Zipursky, Linda Dodds, Congenital abnormalities and childhood cancer Cancer. ,vol. 103, pp. 1939- 1948 ,(2005) , 10.1002/CNCR.20985
William E. Brenner, David A. Edelman, Charles H. Hendricks, A standard of fetal growth for the united states of America American Journal of Obstetrics and Gynecology. ,vol. 126, pp. 555- 564 ,(1976) , 10.1016/0002-9378(76)90748-1
Judith A. Schwartzbaum, Influence of the mother's prenatal drug consumption on risk of neuroblastoma in the child. American Journal of Epidemiology. ,vol. 135, pp. 1358- 1367 ,(1992) , 10.1093/OXFORDJOURNALS.AJE.A116247
Elizabeth C. Bluhm, Julie Daniels, Brad H. Pollock, Andrew F. Olshan, Maternal use of recreational drugs and neuroblastoma in offspring: a report from the Children's Oncology Group (United States). Cancer Causes & Control. ,vol. 17, pp. 663- 669 ,(2006) , 10.1007/S10552-005-0580-3
William D. Foulkes, Paul N. Buu, Denis Filiatrault, Jean-Marie Leclerc, Steven A. Narod, Excess of congenital abnormalities in French‐Canadian children with neuroblastoma: A case series study from Montreal Medical and Pediatric Oncology. ,vol. 29, pp. 272- 279 ,(1997) , 10.1002/(SICI)1096-911X(199710)29:4<272::AID-MPO7>3.0.CO;2-J
Joachim Schüz, Michele R. Forman, Birthweight by gestational age and childhood cancer Cancer Causes & Control. ,vol. 18, pp. 655- 663 ,(2007) , 10.1007/S10552-007-9011-Y
A. Thompson, S. R. Lummis, 5-HT3 receptors. Current Pharmaceutical Design. ,vol. 12, pp. 3615- 3630 ,(2006) , 10.2174/138161206778522029
Joseph P. Neglia, Brad H. Pollock, Shannon E. G. Hamrick, Andrew F. Olshan, Association of pregnancy history and birth characteristics with neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. Paediatric and Perinatal Epidemiology. ,vol. 15, pp. 328- 337 ,(2001) , 10.1046/J.1365-3016.2001.0376A.X
AE Altmann, JL Halliday, GG Giles, Associations between congenital malformations and childhood cancer. A register-based case-control study. British Journal of Cancer. ,vol. 78, pp. 1244- 1249 ,(1998) , 10.1038/BJC.1998.662